• 尊龙凯时(中国)人生就是搏!

    • [Product Name]
      Generic Name: Calcium Hydrogen Phosphate Chewable Tablets
    • [Ingredients]
      Each tablet contains 0.15g Calcium Hydrogen Phosphate. Excipients: Sucrose, Corn Starch, Food Flavoring, Food Coloring, Magnesium Stearate.
    • [Description]
      White, light yellow or light red tablets.
    • [Category]
      Non-prescription mineral supplement.
    • [Indications]
      For prevention and treatment of calcium deficiency, including osteoporosis, tetany, osteogenesis imperfecta, rickets, and calcium supplementation for children, pregnant and lactating women, menopausal women, and the elderly.
    • [Specification]
      0.15g
    • [Administration and Dosage]
      For oral administration. Chew and swallow. Adults: 3-6 tablets per time, 3 times a day. After meals.
    • [Adverse Reactions]
      Occasional constipation.
    • [Contraindications]
      Contraindicated in patients with hypercalcemia, hypercalciuria, calcium-containing kidney stones or history of kidney stones.
    • [Precautions]
      [Precautions] 1. Use with caution in patients with cardiac or renal insufficiency 2. Contraindicated for those allergic to this product; use with caution if allergic-prone. 3. It should not be used when the properties of this medicine have changed. 4. It should be kept out of reach of children. 5. If you are using other medicine, please consult your physician or pharmacist before using this medicine. [Drug Interactions] 1. Avoid concurrent use with digitalis medications. 2. Large consumption of alcoholic and caffeinated beverages, and heavy smoking may inhibit calcium absorption. 3. Large consumption of high-fiber foods may inhibit calcium absorption due to formation of poorly absorbable compounds. 4. Reduced absorption when used with phenytoin sodium and tetracyclines. 5. Vitamin D, contraceptives, and estrogens may increase calcium absorption. 6. Increased aluminum absorption when taken with aluminum-containing antacids. 7. Risk of hypercalcemia when used with thiazide diuretics (due to increased tubular reabsorption of calcium). 8. Monitor for arrhythmias when used with potassium-containing medications. 9. Drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
    • [Pharmacological Action]
      Participates in bone formation, bone tissue reconstruction after fractures, muscle contraction, nerve transmission, blood coagulation, and reduces capillary permeability.
    • [Storage]
      Store in tightly sealed container.
    • [Package]
      High-density polyethylene bottle for oral solid medications, 90 tablets per bottle.
    • [Shelf Life]
      Provisional 24 months
    • [Drug Standards]
      National National Drug Standard for Chemical Drugs, Volume XV, WS-10001-(HD-1394)-2003
    • [Approval Number]
      GYZZ H41025252
    • [Revision Date]
      December 01, 2015
    • [Marketing Authorization Holder]
      Taikang Haien Pharmaceutical Co., Ltd. Address: Taikang Industrial Cluster Area
    • [Manufacturer]
      Taikang Haien Pharmaceutical Co., Ltd.